EASTON BIOPHARMACEUTICALS: Ailamod Tablets have obtained a drug registration certificate
I'm PortAI, I can summarize articles.
EASTON BIOPHARMACEUTICALS announced that its wholly-owned subsidiary Chengdu ShuoDe Pharmaceutical has obtained the "Drug Registration Certificate" issued by the National Medical Products Administration. The drug is Elamomab tablets, indicated for active rheumatoid arthritis, and is classified as a Category B drug in the National Basic Medical Insurance Drug List for 2024
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments